Beacon Biosignals, Inc.

SaaS & Software Boston, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
SaaS & Software
Headquarters
Boston, MA
Street
22 Boston Wharf Road
Zip
02210

Offering

Total offering
$103.3M
Amount sold
$103.3M
First sale
Oct 7, 2025
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
43

How this filing compares

Ranked #8 of 244 SaaS & Software filings in April 2026 by offering amount.

Median SaaS & Software filing in April 2026: $4M. This offering is 25.8× the median.

Other Massachusetts filings this week: ALPINE TORTILLA HOLDCO, INC., Base Camp Fund, Base Camp Fund II, BROOKDALE INTERNATIONAL PARTNERS, L.P., Cahaba Partners Core Fixed Income Fund

Leadership

Jacob A. Donoghue, M.D., Ph.D. — Executive Officer (also: Director)

Jarrett Revels — Executive Officer

Caitlin Donovan — Director

Pavel Raifeld — Director

Naveen Rao — Director

Filing details

Beacon Biosignals, Inc. filed a Form D with the SEC on April 15, 2026.

Other newest SaaS & Software companies

Other newest companies in Massachusetts